Hedge Fund - Portolan Capital Management
Anika Therapeutics Inc. (ANIK)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q3 (2023-09-30) | $0 | 0% | 0 | $20.74 |
| 2 | 2023 - Q2 (2023-06-30) | $2,822,259 | 0.24% | 108,632 | $26.76 |
| 3 | 2023 - Q1 (2023-03-31) | $6,176,954 | 0.58% | 215,075 | $29.76 |
| 4 | 2022 - Q4 (2022-12-31) | $6,153,840 | 0.61% | 207,900 | $28.44 |
| 5 | 2022 - Q3 (2022-09-30) | $5,584,000 | 0.59% | 234,603 | $23.01 |
| 6 | 2022 - Q2 (2022-06-30) | $5,267,000 | 0.53% | 235,972 | $22.31 |
| 7 | 2021 - Q3 (2021-09-30) | $0 | 0% | 0 | $41.19 |
| 8 | 2021 - Q2 (2021-06-30) | $2,172,000 | 0.15% | 50,177 | $42.59 |
| 9 | 2020 - Q4 (2020-12-31) | $0 | 0% | 0 | $37.95 |
| 10 | 2020 - Q3 (2020-09-30) | $273,000 | 0.03% | 7,708 | $36.12 |
| 11 | 2020 - Q2 (2020-06-30) | $370,000 | 0.04% | 9,814 | $32.95 |
| 12 | 2020 - Q1 (2020-03-31) | $319,000 | 0.04% | 11,032 | $40.45 |
| 13 | 2019 - Q4 (2019-12-31) | $750,000 | 0.07% | 14,461 | $58.09 |
| 14 | 2019 - Q3 (2019-09-30) | $794,000 | 0.08% | 14,461 | $51.34 |
| 15 | 2019 - Q2 (2019-06-30) | $627,000 | 0.06% | 15,428 | $36.46 |
| 16 | 2019 - Q1 (2019-03-31) | $443,000 | 0.04% | 14,656 | $34.25 |
| 17 | 2018 - Q4 (2018-12-31) | $3,983,000 | 0.49% | 118,509 | $36.09 |
| 18 | 2018 - Q3 (2018-09-30) | $5,542,000 | 0.54% | 131,382 | $39.51 |
| 19 | 2018 - Q2 (2018-06-30) | $5,187,000 | 0.52% | 162,080 | $41.18 |
| 20 | 2018 - Q1 (2018-03-31) | $2,880,000 | 0.31% | 57,932 | $56.50 |
| 21 | 2017 - Q4 (2017-12-31) | $785,000 | 0.08% | 14,556 | $55.35 |
| 22 | 2017 - Q3 (2017-09-30) | $845,000 | 0.1% | 14,566 | $52.27 |
| 23 | 2017 - Q2 (2017-06-30) | $719,000 | 0.09% | 14,566 | $46.05 |
| 24 | 2017 - Q1 (2017-03-31) | $643,000 | 0.08% | 14,807 | $47.74 |
| 25 | 2016 - Q4 (2016-12-31) | $3,324,000 | 0.44% | 67,892 | $46.23 |
| 26 | 2016 - Q3 (2016-09-30) | $3,123,000 | 0.42% | 65,275 | $49.40 |
| 27 | 2016 - Q2 (2016-06-30) | $2,765,000 | 0.39% | 51,540 | $47.12 |
| 28 | 2016 - Q1 (2016-03-31) | $5,856,000 | 0.78% | 130,939 | $40.56 |
| 29 | 2015 - Q4 (2015-12-31) | $18,645,000 | 2.36% | 488,595 | $38.25 |
| 30 | 2015 - Q3 (2015-09-30) | $20,335,000 | 2.69% | 638,849 | $34.87 |
| 31 | 2015 - Q2 (2015-06-30) | $16,330,000 | 2.28% | 494,413 | $35.67 |
| 32 | 2015 - Q1 (2015-03-31) | $15,005,000 | 2.75% | 364,463 | $40.43 |
| 33 | 2014 - Q4 (2014-12-31) | $12,553,000 | 2.51% | 308,131 | $39.09 |
| 34 | 2014 - Q3 (2014-09-30) | $9,269,000 | 2.1% | 252,833 | $43.21 |
| 35 | 2014 - Q2 (2014-06-30) | $10,058,000 | 2.19% | 217,105 | $44.47 |
The displayed share prices are average quarterly stock market prices.